Published in Circulation on January 21, 2014
Association between three eNOS polymorphisms and intracranial aneurysms risk: a meta-analysis. Medicine (Baltimore) (2015) 0.82
Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke (2015) 0.75
Carotid siphon morphology: Is it associated with posterior communicating aneurysms? Interv Neuroradiol (2016) 0.75
Morphological and Hemodynamic Discriminators for Rupture Status in Posterior Communicating Artery Aneurysms. PLoS One (2016) 0.75
An S1P1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration. Br J Pharmacol (2017) 0.75
Downregulation of T cell immunoglobulin and mucin protein 3 in the pathogenesis of intracranial aneurysm. Inflammation (2015) 0.75
Clinical value of homodynamic numerical simulation applied in the treatment of cerebral aneurysm. Exp Ther Med (2017) 0.75
Tissue cells feel and respond to the stiffness of their substrate. Science (2005) 23.42
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
Flow-mediated endothelial mechanotransduction. Physiol Rev (1995) 10.13
Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol (1996) 9.95
The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development (1988) 8.84
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature (2005) 6.86
Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol (2004) 6.83
Intracranial aneurysms. N Engl J Med (1997) 5.73
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol (2009) 5.41
Cerebral aneurysms. N Engl J Med (2006) 4.88
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci U S A (2004) 4.31
Mechanotransduction gone awry. Nat Rev Mol Cell Biol (2009) 4.00
The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng (2007) 3.40
Characterization of cerebral aneurysms for assessing risk of rupture by using patient-specific computational hemodynamics models. AJNR Am J Neuroradiol (2005) 3.33
Efficient pipeline for image-based patient-specific analysis of cerebral aneurysm hemodynamics: technique and sensitivity. IEEE Trans Med Imaging (2005) 3.28
Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J (2001) 3.22
Magnitude and role of wall shear stress on cerebral aneurysm: computational fluid dynamic study of 20 middle cerebral artery aneurysms. Stroke (2004) 3.21
Haemodynamic shear stress activates a K+ current in vascular endothelial cells. Nature (1988) 3.12
Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (2006) 3.01
Complex hemodynamics at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke (2007) 2.58
Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke (2004) 2.53
G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc Natl Acad Sci U S A (2006) 2.21
Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol (2012) 2.09
Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke (2011) 2.07
Genomics of human intracranial aneurysm wall. Stroke (2009) 2.06
Wall shear stress on ruptured and unruptured intracranial aneurysms at the internal carotid artery. AJNR Am J Neuroradiol (2008) 1.87
Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res (2009) 1.78
Inflammation and intracranial aneurysms. Neurosurgery (1999) 1.74
Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab (2012) 1.73
Endothelial cell functions. J Cell Physiol (2003) 1.69
Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke (2008) 1.64
Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke (2006) 1.56
Characterization of volumetric flow rate waveforms in the normal internal carotid and vertebral arteries. Physiol Meas (2005) 1.48
Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation (1997) 1.48
Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke (2009) 1.45
Computational fluid dynamics modeling of intracranial aneurysms: effects of parent artery segmentation on intra-aneurysmal hemodynamics. AJNR Am J Neuroradiol (2006) 1.45
Incidence and outcome of multiple intracranial aneurysms in a defined population. Stroke (2003) 1.40
Genesis of cerebral aneurysms--an update. Acta Neurochir (Wien) (2001) 1.37
Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery (1997) 1.36
PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol (2011) 1.34
Conformational changes and signaling in cell and matrix physics. Curr Biol (2009) 1.33
TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag (2008) 1.31
Phase-contrast magnetic resonance imaging measurements in intracranial aneurysms in vivo of flow patterns, velocity fields, and wall shear stress: comparison with computational fluid dynamics. Magn Reson Med (2009) 1.26
Hemodynamics in a cerebral artery before and after the formation of an aneurysm. AJNR Am J Neuroradiol (2006) 1.25
Triggers of subarachnoid hemorrhage: role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke (2003) 1.20
Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery (2005) 1.20
An animal model of cerebral aneurysms. Neuropathol Appl Neurobiol (1987) 1.20
Hemodynamics and bleb formation in intracranial aneurysms. AJNR Am J Neuroradiol (2009) 1.17
PIV-measured versus CFD-predicted flow dynamics in anatomically realistic cerebral aneurysm models. J Biomech Eng (2008) 1.17
Effects of freezing and cryopreservation on the mechanical properties of arteries. Ann Biomed Eng (2006) 1.17
Collagen fiber formation in repair tissue: development of strength and toughness. Coll Relat Res (1985) 1.17
Virtual angiography for visualization and validation of computational models of aneurysm hemodynamics. IEEE Trans Med Imaging (2005) 1.14
Axial mechanical properties of fresh human cerebral blood vessels. J Biomech Eng (2003) 1.14
Computational fluid dynamics modeling of intracranial aneurysms: qualitative comparison with cerebral angiography. Acad Radiol (2007) 1.12
Has there been a decline in subarachnoid hemorrhage mortality? Stroke (1989) 1.11
Network-based gene expression analysis of intracranial aneurysm tissue reveals role of antigen presenting cells. Neuroscience (2008) 1.11
Hemodynamic forces regulate mural macrophage infiltration in experimental aortic aneurysms. Exp Mol Pathol (2004) 1.11
Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke (2007) 1.10
Clinicopathological study of cerebral aneurysms. Origin, rupture, repair, and growth. J Neurosurg (1978) 1.09
Hemodynamics and vascular endothelial biology. J Cardiovasc Pharmacol (1993) 1.08
Progressive aneurysm development following hemodynamic insult. J Neurosurg (2010) 1.07
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol (2007) 1.07
Role of the bloodstream impacting force and the local pressure elevation in the rupture of cerebral aneurysms. Stroke (2005) 1.05
Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? Stroke (2009) 1.05
Comparison of the elastic properties of human intracranial arteries and aneurysms. Can J Physiol Pharmacol (1972) 1.02
Comparative velocity investigations in cerebral arteries and aneurysms: 3D phase-contrast MR angiography, laser Doppler velocimetry and computational fluid dynamics. NMR Biomed (2009) 1.02
Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery (2005) 1.01
Cellular and molecular responses of the basilar terminus to hemodynamics during intracranial aneurysm initiation in a rabbit model. J Vasc Res (2011) 1.01
Identification of quantifiable hemodynamic factors in the assessment of cerebral aneurysm behavior. On behalf of the Subcommittee on Biorheology of the Scientific and Standardization Committee of the ISTH. Thromb Haemost (1996) 0.99
Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab Invest (2009) 0.98
Contribution of mast cells to cerebral aneurysm formation. Curr Neurovasc Res (2010) 0.97
Complement system becomes activated by the classical pathway in intracranial aneurysm walls. Lab Invest (2009) 0.97
Directional wall strength in saccular brain aneurysms from polarized light microscopy. Ann Biomed Eng (2000) 0.96
Computational fluid dynamics simulations of intracranial aneurysms at varying heart rates: a "patient-specific" study. J Biomech Eng (2009) 0.96
Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 0.95
Strength, elasticity and viscoelastic properties of cerebral aneurysms. Heart Vessels (1989) 0.95
A model for saccular cerebral aneurysm growth by collagen fibre remodelling. J Theor Biol (2007) 0.95
Intra-aneurysmal flow patterns and wall shear stresses calculated with computational flow dynamics in an anterior communicating artery aneurysm depend on knowledge of patient-specific inflow rates. Acta Neurochir (Wien) (2009) 0.92
Temporal variations of wall shear stress parameters in intracranial aneurysms--importance of patient-specific inflow waveforms for CFD calculations. Acta Neurochir (Wien) (2010) 0.92
Hemodynamic mechanisms underlying cerebral aneurysm pathogenesis. J Clin Neurosci (2011) 0.92
Patient-specific flow analysis of brain aneurysms at a single location: comparison of hemodynamic characteristics in small aneurysms. Med Biol Eng Comput (2008) 0.92
Complementary inhibition of cerebral aneurysm formation by eNOS and nNOS. Lab Invest (2011) 0.91
Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats. Neurosurgery (2010) 0.88
Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol (2000) 0.87
Monocyte chemoattractant protein-1 mRNA in human intracranial aneurysm walls. Zhonghua Yu Fang Yi Xue Za Zhi (2002) 0.86
Effect of non-newtonian behavior on hemodynamics of cerebral aneurysms. J Biomech Eng (2009) 0.85
Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Ther (2010) 0.81
Association between semicarbazide-sensitive amine oxidase, a regulator of the glucose transporter, and elastic lamellae thinning during experimental cerebral aneurysm development: laboratory investigation. J Neurosurg (2008) 0.79
Electron microscopic study of the arterial wall in the cerebral aneurysms. Rom J Morphol Embryol (2008) 0.77
Hemodynamics in aneurysm. Comput Biomed Res (1996) 0.76
Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med (2015) 5.36
Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol (2007) 4.62
Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings. Circulation (2011) 3.16
Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem (2007) 3.06
Luminal flow patterns dictate arterial drug deposition in stent-based delivery. J Control Release (2008) 1.90
Tissue engineering therapy for cardiovascular disease. Circ Res (2003) 1.87
Prediction of the localization of high-risk coronary atherosclerotic plaques on the basis of low endothelial shear stress: an intravascular ultrasound and histopathology natural history study. Circulation (2008) 1.74
Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation (2003) 1.72
Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor. Circulation (2012) 1.70
Heparanase alters arterial structure, mechanics, and repair following endovascular stenting in mice. Circ Res (2008) 1.64
Endovascular treatment of symptomatic intracranial stenosis with the Wingspan stent system and Gateway PTA balloon: a multicenter series of 60 patients with acute and midterm results. J Neurosurg (2011) 1.51
Stromal endothelial cells directly influence cancer progression. Sci Transl Med (2011) 1.46
In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat Mater (2011) 1.46
Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation (2002) 1.45
Ultrasound-guided percutaneous delivery of tissue-engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a porcine model. J Vasc Surg (2012) 1.42
Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res (2005) 1.32
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A (2004) 1.32
Aldehyde-amine chemistry enables modulated biosealants with tissue-specific adhesion. Adv Mater (2009) 1.31
Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release (2007) 1.29
Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol (2005) 1.27
Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation (2005) 1.26
Endovascular treatment of intracranial wide-necked aneurysms using three-dimensional coils: predictors of immediate anatomic and clinical results. AJNR Am J Neuroradiol (2004) 1.25
Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress: a serial, in vivo intravascular ultrasound study. Circulation (2010) 1.19
Characterization of star adhesive sealants based on PEG/dextran hydrogels. Macromol Biosci (2009) 1.18
Vascular bed origin dictates flow pattern regulation of endothelial adhesion molecule expression. Am J Physiol Heart Circ Physiol (2007) 1.18
Luminal flow amplifies stent-based drug deposition in arterial bifurcations. PLoS One (2009) 1.17
Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res (2003) 1.12
Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res (2008) 1.11
Arterial ultrastructure influences transport of locally delivered drugs. Circ Res (2002) 1.11
Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation (2011) 1.11
Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation (2002) 1.11
Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds? Circulation (2003) 1.06
Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem (2007) 1.05
Cardiology is flow. Circulation (2006) 1.04
Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg (2007) 1.04
Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits. Circulation (2003) 1.03
Impact of transport and drug properties on the local pharmacology of drug-eluting stents. Int J Cardiovasc Intervent (2003) 1.02
Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J Clin Invest (2004) 1.02
Matrix embedding alters the immune response against endothelial cells in vitro and in vivo. Circulation (2005) 1.02
Recovery of third nerve palsy after endovascular treatment of posterior communicating artery aneurysms. World Neurosurg (2009) 1.02
Lesion complexity determines arterial drug distribution after local drug delivery. J Control Release (2009) 1.00
Smooth muscle cells orchestrate the endothelial cell response to flow and injury. Circulation (2010) 1.00
Unruptured intracranial aneurysms treated by three-dimensional coil embolization: evaluation of the postoperative aneurysm occlusion volume. Neuroradiology (2005) 0.99
The role of low endothelial shear stress in the conversion of atherosclerotic lesions from stable to unstable plaque. Curr Opin Cardiol (2009) 0.98
Dysfunctional endothelial cells directly stimulate cancer inflammation and metastasis. Int J Cancer (2013) 0.98
Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - a position paper endorsed by ESMINT and ESNR : part II: methodology of future trials. Neuroradiology (2012) 0.98
Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation (2005) 0.98
Solitaire AB stent-assisted coiling of wide-necked intracranial aneurysms: short-term results from a prospective, consecutive, European multicentric study. Neuroradiology (2013) 0.98
Viscoelastic adhesive mechanics of aldehyde-mediated soft tissue sealants. Biomaterials (2008) 0.97
Natural tissue microenvironmental conditions modulate adhesive material performance. Langmuir (2012) 0.97
Regulation of endothelial cell proliferation by primary monocytes. Arterioscler Thromb Vasc Biol (2007) 0.96
Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair. Proc Natl Acad Sci U S A (2008) 0.96
Thrombus causes fluctuations in arterial drug delivery from intravascular stents. J Control Release (2008) 0.95
Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo- and xenogeneic models. FASEB J (2007) 0.94
Solitaire AB stent-assisted coiling of wide-necked intracranial aneurysms: mid-term results from the SOLARE Study. Neurosurgery (2014) 0.94
Endovascular treatment of two concomitant causes of pulsatile tinnitus: sigmoid sinus stenosis and ipsilateral jugular bulb diverticulum. Case report and literature review. Acta Neurochir (Wien) (2011) 0.94
Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle. Proc Natl Acad Sci U S A (2012) 0.94
Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques. Atherosclerosis (2008) 0.93
Preclinical evaluation of drug-eluting stents for peripheral applications: recommendations from an expert consensus group. Circulation (2004) 0.93
Cells in fluidic environments are sensitive to flow frequency. J Cell Physiol (2005) 0.92
Endothelial immunogenicity--a matter of matrix microarchitecture. Thromb Haemost (2007) 0.91
Endothelial cell-matrix interactions determine maturation of dendritic cells. Eur J Immunol (2007) 0.90
Quasi-steady-state kinetics at enzyme and substrate concentrations in excess of the Michaelis-Menten constant. J Theor Biol (2006) 0.90
Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am J Physiol Heart Circ Physiol (2007) 0.90
Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting. Rev Endocr Metab Disord (2010) 0.90
The evolution of endothelial regulatory paradigms in cancer biology and vascular repair. Cancer Res (2011) 0.90
Cell-matrix contact prevents recognition and damage of endothelial cells in states of heightened immunity. Circulation (2006) 0.90
Endovascular treatment of 404 intracranial aneurysms treated with nexus detachable coils: short-term and mid-term results from a prospective, consecutive, European multicenter study. Acta Neurochir (Wien) (2014) 0.90
Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med (2003) 0.90
Analysis of compartmental models of ligand-induced endocytosis. J Theor Biol (2004) 0.89
The effect of three-dimensional matrix-embedding of endothelial cells on the humoral and cellular immune response. Semin Immunol (2008) 0.89
Regulation of heparanase expression in coronary artery disease in diabetic, hyperlipidemic swine. Atherosclerosis (2010) 0.89
Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes. Biochem J (2007) 0.88
Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation (2004) 0.87
A structural model that explains the effects of hyperglycemia on collagenolysis. Biophys J (2003) 0.87
Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis. J Biomech Eng (2002) 0.87
Anti-atherosclerotic therapy based on botanicals. Recent Pat Cardiovasc Drug Discov (2013) 0.87
Augmentation of postswelling surgical sealant potential of adhesive hydrogels. J Biomed Mater Res A (2010) 0.86
Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activation. J Biol Chem (2002) 0.86
Effect of pre-adsorbed proteins on attachment, proliferation, and function of endothelial cells. J Cell Physiol (2002) 0.86
Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB. Blood (2005) 0.86
Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant (2014) 0.86
Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. J Am Coll Cardiol (2012) 0.86
Mechanisms of tissue uptake and retention in zotarolimus-coated balloon therapy. Circulation (2013) 0.85
The effect of substrate modulus on the growth and function of matrix-embedded endothelial cells. Biomaterials (2012) 0.85
Pushing drug-eluting stents into uncharted territory: simpler than you think--more complex than you imagine. Circulation (2006) 0.85
Local and systemic drug competition in drug-eluting stent tissue deposition properties. J Control Release (2005) 0.85
Dural arteriovenous fistula of the anterior fossa treated with the Onyx liquid embolic system and the Sonic microcatheter. Neuroradiology (2008) 0.85
Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress. Arterioscler Thromb Vasc Biol (2013) 0.85
Tubular bridges for bronchial epithelial cell migration and communication. PLoS One (2010) 0.85
Environmental influences on endovascular stent platelet reactivity: an in vitro comparison of stainless steel and gold surfaces. J Biomed Mater Res A (2004) 0.85
Impact of flow pulsatility on arterial drug distribution in stent-based therapy. J Control Release (2013) 0.85
Stent elution rate determines drug deposition and receptor-mediated effects. J Control Release (2012) 0.84
C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol (2007) 0.84
Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2. Arterioscler Thromb Vasc Biol (2011) 0.84
Cellular bridges: Routes for intercellular communication and cell migration. Commun Integr Biol (2010) 0.84
Collagen fragments modulate innate immunity. Exp Biol Med (Maywood) (2007) 0.84
The role of scaffold microarchitecture in engineering endothelial cell immunomodulation. Biomaterials (2012) 0.84
Engineered arterial models to correlate blood flow to tissue biological response. Ann N Y Acad Sci (2012) 0.83
Delivery site of perivascular endothelial cell matrices determines control of stenosis in a porcine femoral stent model. J Vasc Interv Radiol (2009) 0.83